2025 Basser Center Global Prize Awarded to Ephrat Levy-Lahad Penn Medicine News News Levy-Lahad has been recognized for leading population-based BRCA screening programs. Latest News FDA Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018 Genetic Study Makes Testing More Accessible Jewish Exponent News | March 2018 Many Women Mistake Common Symptom of Ovarian Cancer for Indigestion Healthline News | March 2018 Relearning How to Date After My Double Mastectomy The Cut News | March 2018 The Role of Biomarkers in Patients with Breast Cancer Targeted Oncology News | March 2018 Think Before Trying Home Breast Cancer Gene Tests, Experts Urge USA Today News | March 2018 When it Comes to Home Cancer Tests, Think Before You Spit USA Today News | March 2018 BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Pagination First page« First Previous page‹‹ … Page8 Page9 Page10 Page11 Page12 Page13 Page14 Current page15 Page16 Next page›› Last pageLast »
2025 Basser Center Global Prize Awarded to Ephrat Levy-Lahad Penn Medicine News News Levy-Lahad has been recognized for leading population-based BRCA screening programs.
FDA Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018
BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018
Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018
Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018
Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017
